Device Mi - Nuclear Medicine (Incl. Petnet & Mibr)

Biograph Vision 600 (8 Ring/64 Ct)

Payments companies reported to CMS as associated with Biograph Vision 600 (8 Ring/64 Ct). "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$80Kassociated payments (2023-2025)
242clinicians with associated payments
1company reporting

By year

2023 $9,170
2024 $23K
2025 $49K

Payments reported as associated with Biograph Vision 600 (8 Ring/64 Ct), per program year, as reported to CMS.

Who makes it

Specialties most often involved

Diagnostic Radiology $49K
Body Imaging $13K
Nuclear Medicine $7,328
Vascular & Interventional Radiology $3,468
Cardiovascular Disease $3,167
Nuclear Radiology $1,151

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Biograph Vision 600 (8 Ring/64 Ct)

These are the largest totals companies reported as associated with Biograph Vision 600 (8 Ring/64 Ct). They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Javier Villanueva-Meyer San Francisco, CA Diagnostic Radiology $12,235.58
Spencer Behr San Francisco, CA Body Imaging $11,811.82
Robert Flavell New York, NY Diagnostic Radiology $11,811.82
Ryan Avery Chicago, IL Diagnostic Radiology $4,379.94
Munir Ghesani Princeton, NJ Nuclear Medicine $2,689.07
Vikas Prasad Saint Louis, MO Nuclear Medicine $1,545.00
Ghassan El Haddad Tampa, FL Vascular & Interventional Radiology $1,443.38
Edgar Cheng Bethlehem, PA Diagnostic Radiology $1,199.29
Sajjad Ahmad Saint Joseph, MO Cardiovascular Disease $1,166.81
Jacobo Kirsch Weston, FL Diagnostic Radiology $990.57

Prescribed Biograph Vision 600 (8 Ring/64 Ct)?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.